266 related articles for article (PubMed ID: 32759846)
1. Post-Translational Regulation of ARF: Perspective in Cancer.
Seo J; Seong D; Lee SR; Oh DB; Song J
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32759846
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Network of ARF in Cancer Development.
Ko A; Han SY; Song J
Mol Cells; 2018 May; 41(5):381-389. PubMed ID: 29665672
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of ARF regulation that control senescence and cancer.
Ko A; Han SY; Song J
BMB Rep; 2016 Nov; 49(11):598-606. PubMed ID: 27470213
[TBL] [Abstract][Full Text] [Related]
4. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of
van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370
[TBL] [Abstract][Full Text] [Related]
5. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
[TBL] [Abstract][Full Text] [Related]
6. MdmX inhibits ARF mediated Mdm2 sumoylation.
Ghosh M; Weghorst K; Berberich SJ
Cell Cycle; 2005 Apr; 4(4):604-8. PubMed ID: 15876864
[TBL] [Abstract][Full Text] [Related]
7. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf).
Ewing SJ; Zhu S; Zhu F; House JS; Smart RC
Cell Death Differ; 2008 Nov; 15(11):1734-44. PubMed ID: 18636078
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines.
Roberti A; Rizzolio F; Lucchetti C; de Leval L; Giordano A
Cell Cycle; 2011 Jan; 10(1):127-34. PubMed ID: 21200153
[TBL] [Abstract][Full Text] [Related]
9. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
10. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
11. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
12. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
[TBL] [Abstract][Full Text] [Related]
13. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
Zhang Y; Xiong Y
Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
[TBL] [Abstract][Full Text] [Related]
14. Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
Inoue K; Fry EA
Int J Cancer; 2016 Jul; 139(1):33-41. PubMed ID: 26802432
[TBL] [Abstract][Full Text] [Related]
15. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppression by ARF: gatekeeper and caretaker.
Dominguez-Brauer C; Brauer PM; Chen YJ; Pimkina J; Raychaudhuri P
Cell Cycle; 2010 Jan; 9(1):86-9. PubMed ID: 20016279
[TBL] [Abstract][Full Text] [Related]
17. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
[TBL] [Abstract][Full Text] [Related]
18. The ARF tumor suppressor: keeping Myc on a leash.
Gregory MA; Qi Y; Hann SR
Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
[TBL] [Abstract][Full Text] [Related]
19. Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.
Minges JT; Grossman G; Zhang P; Kafri T; Wilson EM
J Biol Chem; 2015 Oct; 290(41):25174-87. PubMed ID: 26330556
[TBL] [Abstract][Full Text] [Related]
20. MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.
Walter RF; Mairinger FD; Ting S; Vollbrecht C; Mairinger T; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J
Br J Cancer; 2015 Mar; 112(5):883-90. PubMed ID: 25668009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]